Outcome-based agreements in Europe

Opportunities, challenges and future directions

From China to the world: Advancing a biotech’s oncology therapy to achieve FDA accelerated approval

Primary Sclerosing Cholangitis: Patient Voices in Rare Disease Care

Precision medicine in 2026: What it means for complex disease development

Stay ahead of the curve: How AI is reshaping ophthalmology trials at every stage

How can AI in ophthalmology transform each critical stage of your trial journey?

Dedicated FTE: Agile. Scalable. Dedicated.

Obesity Day Insights: Innovation Across the Evolving Obesity Drug Pipeline